DENTSPLY SIRONA (XRAY) HR chief reports 5,657 shares withheld for taxes

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. senior vice president and chief human resources officer Andrea L. Frohning reported tax-related share dispositions tied to vesting equity awards. On March 3 and 4, 2026, a total of 5,657 shares of common stock were withheld to cover tax liabilities at prices between $13.30 and $13.44 per share. These are coded as tax-withholding dispositions, not open-market sales. After the most recent withholding, Frohning directly holds 37,206.252 shares of DENTSPLY SIRONA common stock.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Frohning Andrea L.

Role SVP, CHRO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	690	$13.44	$9K
Tax Withholding	Common Stock	2,990	$13.30	$40K
Tax Withholding	Common Stock	1,977	$13.30	$26K

Holdings After Transaction: Common Stock — 37,206.252 shares (Direct)

Footnotes (1)

Shares withheld to cover taxes related to the vesting of the reporting person's Performance-Based Restricted Stock Units and dividend equivalent units previously reported in Table I. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/05/2026 - 07:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frohning Andrea L.

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

28277

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, CHRO

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2026		F		2,990⁽¹⁾	D	$13.3	39,873.252	D
Common Stock	03/03/2026		F		1,977⁽²⁾	D	$13.3	37,896.252	D
Common Stock	03/04/2026		F		690⁽²⁾	D	$13.44	37,206.252	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares withheld to cover taxes related to the vesting of the reporting person's Performance-Based Restricted Stock Units and dividend equivalent units previously reported in Table I.

2. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Andrea Frohning	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did DENTSPLY SIRONA (XRAY) executive Andrea L. Frohning report on this Form 4?

Andrea L. Frohning reported tax-withholding dispositions of common stock related to vesting equity awards. Shares were withheld by the company to cover tax liabilities when restricted and performance-based stock units vested, rather than sold in the open market.

How many DENTSPLY SIRONA (XRAY) shares were withheld for Andrea Frohning’s taxes?

A total of 5,657 DENTSPLY SIRONA common shares were withheld for taxes. The transactions involved 2,990 shares and 1,977 shares on March 3, 2026, and 690 shares on March 4, 2026, all designated as tax-withholding dispositions.

At what prices were DENTSPLY SIRONA (XRAY) shares withheld in Andrea Frohning’s Form 4?

The withheld shares were valued at $13.30 and $13.44 per share. On March 3, 2026, 4,967 shares were withheld at $13.30, and on March 4, 2026, 690 shares were withheld at $13.44, solely to satisfy tax obligations on vesting awards.

Does Andrea L. Frohning still hold DENTSPLY SIRONA (XRAY) shares after these tax withholdings?

Yes, Andrea L. Frohning continues to hold DENTSPLY SIRONA shares directly. After the latest tax-withholding disposition on March 4, 2026, her direct ownership stands at 37,206.252 shares of the company’s common stock, according to the reported totals.

Were Andrea Frohning’s DENTSPLY SIRONA (XRAY) Form 4 transactions open-market sales?

No, the transactions were not open-market sales. They were classified with code F as shares withheld by the company to pay tax liabilities arising from vesting restricted and performance-based stock units, based on the filing’s transaction codes and footnotes.

What do the Form 4 footnotes say about Andrea Frohning’s DENTSPLY SIRONA (XRAY) transactions?

The footnotes explain that the shares were withheld to cover taxes on vesting equity awards. They specify that the dispositions relate to performance-based restricted stock units, restricted stock units, and associated dividend equivalent units previously reported in the non-derivative holdings table.